Researchers discover second depth-perception method in brainMarch 17, 2008It's common knowledge that humans and other animals are able to visually judge depth because we have two eyes and the brain compares the images from each. But we can also judge depth with only one eye, and scientists have been searching for how the brain accomplishes that feat. Now, a team led by a scientist at the University of Rochester believes it has discovered the answer in a small part of the brain that processes both the image from a single eye and also with the motion of our bodies. The team of researchers, led by Greg DeAngelis, professor in the Department of Brain and Cognitive Sciences at the University of Rochester, has published the findings in the March 20 online issue of the journal Nature. "It looks as though in this area of the brain, the neurons are combining visual cues and non-visual cues to come up with a unique way to determine depth," says DeAngelis. DeAngelis says that means the brain uses a whole array of methods to gauge depth. In addition to two-eyed "binocular disparity," the brain has neurons that specifically measure our motion, perspective, and how objects pass in front of or behind each other to create an approximation of the three-dimensional world in our minds. The researchers say the findings may help instruct children who were born with misalignment of the eyes to restore more normal functions of binocular vision in the brain. The discovery could also help construct more compelling virtual reality environments someday, says DeAngelis, since we have to know exactly how our brains construct three-dimensional perception to make virtual reality as convincing as possible. The neural mechanism is based on the fact that objects at different distances move across our vision at different speeds due to a phenomenon called motion parallax, says DeAngelis. When staring at a fixed object, any motion we make will cause things nearer than the object to appear to move in the opposite direction, and more distant things to appear to move in the same direction. To figure out the real three-dimensional layout of what it sees, DeAngelis says the brain needs one more piece of information and it pulls in this information from the motion of the eyeball itself. According to DeAngelis, the neurons in the middle temporal area of the brain are combining visual information and physical movement to extract depth information. As the dragon illusion demonstrates, the motion of near and far objects can be confused. But if the eye is moving while tracking the overall movement of the group of objects, it gives the middle temporal neurons enough information to grasp that the object moving fastest in the same direction must be the closest object, and the one moving slowest must be the farthest, says DeAngelis. "We use binocular disparity, occlusion, perspective, and our own motion all together to create a representation of the real, 3D world in our minds," says DeAngelis. University of Rochester |
|||||||||||||||||||||
| Related Neurons Current Events and Neurons News Articles Scripps research scientists find new link between insulin and core body temperature A team led by scientists at The Scripps Research Institute have discovered a direct link between insulin-a hormone long associated with metabolism and metabolic disorders such as diabetes-and core body temperature. New Down syndrome treatment suggested by Stanford/Packard study in mice At birth, children with Down syndrome aren't developmentally delayed. But as they age, these kids fall behind. Memory deficits inherent in Down syndrome hinder learning, making it hard for the brain to collect experiences needed for normal cognitive development. Cognitive dysfunction reversed in mouse model of Down syndrome A study by neuroscientist William C. Mobley, MD, PhD, chair of the Department of Neurosciences at the University of California, San Diego School of Medicine, and colleagues at Stanford University Medical School has demonstrated a possible new approach to slowing the inevitable progression of cognitive decline found in Down's syndrome. Pushing the brain to find new pathways Until recently, scientists believed that, following a stroke, a patient had about six months to regain any lost function. After that, patients would be forced to compensate for the lost function by focusing on their remaining abilities. Scientists decipher the formation of lasting memories Researchers at Karolinska Institutet have discovered a mechanism that controls the brain's ability to create lasting memories. In experiments on genetically manipulated mice, they were able to switch on and off the animals' ability to form lasting memories by adding a substance to their drinking water. Developmental delay could stem from nicotinic receptor deletion The loss of a gene through deletion of genetic material on chromosome 15 is associated with significant abnormalities in learning and behavior, said a consortium of researchers led by Baylor College of Medicine (www.bcm.edu) in a report that appears online today in the journal Nature Genetics. New TMS clinic offers noninvasive treatment for major depression Rush University Medical Center has opened the Transcranial Magnetic Stimulation (TMS) Clinic to offer patients suffering from major depression a safe, effective, non-drug treatment. Researchers explore new ways to prevent spinal cord damage using a vitamin B3 precursor Substances naturally produced by the human body may one day help prevent paralysis following a spinal cord injury, according to researchers at Weill Cornell Medical College. A recent $2.5 million grant from the New York State Spinal Cord Injury Research Board will fund their research investigating this possibility. Estrogen therapy likely must be given soon after menopause to provide stroke protection For estrogen replacement to provide stroke protection, it likely must be given soon after levels drop because of menopause or surgical removal of the ovaries, scientists report in the Journal of Neuroscience. Researchers identify drug candidate for treating spinal muscular atrophy A chemical cousin of the common antibiotic tetracycline might be useful in treating spinal muscular atrophy (SMA), a currently incurable disease that is the leading genetic cause of death in infants. More Neurons Current Events and Neurons News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||